Foresite Capital Management V, LLC

Foresite Capital Management V, LLC has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Alumis Inc., Latigo Biotherapeutics, Inc. and Theseus Pharmaceuticals, Inc. In total, 31 filings cover trades dated from 1 December 2022 to 10 August 2026.

No open-market sale appears; the market trades are 9 purchases worth €45.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.

The median purchase comes to €1.2M. Of 8 purchases, 8 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

On 10 August 2026 came the latest disclosure, a transaction in Latigo Biotherapeutics, Inc. The last purchase on record was published on 10 August 2026, which is 75 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.